Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Cangene seeks approval of VZIG in Canada

July 8, 1999

Allotrap-1258, a rationally designed immunomodulating peptide for the prevention of GvHD

July 6, 1999

Renal allograft survival is prolonged by treatment with anti-CD4-idarubicin immunoconjugate

July 5, 1999

Cerus initiates phase I allogeneic bone marrow transplant study

July 5, 1999

First demonstration of prolonged graft survival with a rationally designed IMPDH inhibitor

July 2, 1999

Jak3 tyrosine kinase inhibitor prolongs allograft survival in rat model

July 2, 1999

IL-15 can act as a substitute for IL-2 in the rejection process

July 2, 1999

Results of European studies on sirolimus discussed at Oslo congress

July 1, 1999

Novartis improves upon an effective transplant drug

July 1, 1999

Acellular pertussis vaccine approved in Canada for adults, adolescents

July 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...